NetComposites Ltd has transferred the rights and ownership of this website to Gardner Business Media Inc.
On 1st January 2020, NetComposites' media assets including netcomposites.com, newsletters and conferences were transferred to Composites World (Gardner Business Media).
This site is no longer being updated. Please direct all enquiries to email@example.com.
For further details see our joint press release.
Diaphorm Technologies, LLC in partnership with CJM Investments Corp. has executed a management led buyout of the Diaphorm Division of Solectria Corp.
Diaphorm is focused on providing innovative solutions to challenging materials problems in the application of structural plastic composites. Supporting these offerings are the Diaphorm patent pending systems and methods for forming thermoplastic composite parts and the patented and patent pending Diaphorm preforming technologies. Of particular note is Diaphorm’s depth of knowledge in developing engineered solutions for the cost effective moulding of a variety of engineered reinforced composite materials such as Twintex, Tepex, Towflex and Schappe TPFL.
According to Christopher Meyers, director of CJM Investments Inc., “Diaphorm Technologies represents an excellent opportunity given the highly skilled team, proprietary technology solutions and innovative manufacturing techniques in a rapidly growing and ever important market.” The process expertise of Diaphorm has been critical in providing support to a wide range of customers spanning the military, sports and automotive sectors. Customers who have taken advantage of Diaphorm’s expertise have included Algonquin Automotive, Bauer Nike Hockey, General Dynamics, Sikorsky Aircraft, Sioux Manufacturing, United Defense LP, and the US Army Research Labs.
Reflecting on future opportunities, Bob Miller, President & CEO of Diaphorm stated: “Our integrated services approach leverages our deep expertise in these composite process technologies needed to help our customers realize high margin, high-performance products and that based upon our new financial strength, Diaphorm will now be able to more rapidly expand its range of capabilities to satisfy an ever growing and demanding customer base.”
For more information visit: